|
|
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
Datoc, MaryLynn A Wednesday, August 01,200l 4:14 PM Dockets, FDA Registration I would like to register to attend the public meeting on food allergens. I am with the FDA, Office of Regulatory Affairs ... more>>
FDADocs 5/6/2008 | 0 (0) | 9 | 0 | 0 | English
DocketDockets No. & OON-1396 Docket FDA Administration Commissioner, FoodLane, and Room Drug 563020852 Fishers Rockville, MD Dear : FDA Commissioner Genetic natural engineering involves scientists to ... more>>
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE Hilton Hotel, The Maryland Room, Silver Spring, MD 8:00 a.m. ??? 12:00 p.m ... more>>
FDADocs 5/9/2008 | 0 (0) | 9 | 0 | 0 | English
FDADocs 5/9/2008 | 0 (0) | 9 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
1Questions and Answers about FDA???s Enforcement Action Against Unapproved Timed-Release Guaifenesin ProductsWhat action is FDA taking concerning timed-release drug products containing ... more>>
FDADocs 5/5/2008 | 0 (0) | 8 | 0 | 0 | English
Sent: To: Subject:Monday, July 30, 2001 2:34 PM Dockets, FDA Registration for Allergen Labeling... Labeling on August 13th. Tina Harper Legislative Analyst FDA 5600 Fishers Lane Room 15-47 Rockville, MD ... more>>
FDADocs 5/5/2008 | 0 (0) | 8 | 0 | 0 | English
FIFTHDIMENSIONINFORMATIONSYSTEMS SPI-FDA-0004.0Effective Date: April 22, 2002 Page 1 of 1SPI -Systemfor Plasma IdentificationTitle: 510(k) Statement510(k) Statement ... more>>
FDADocs 5/8/2008 | 0 (0) | 8 | 0 | 0 | English
FDADocs 5/9/2008 | 0 (0) | 8 | 0 | 0 | English
NASSdocs 6/17/2008 | 0 (0) | 7 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 6 | 0 | 0 | English
IMPLEMENTATION STATUS OF THE CTD IN THE OTHER ICH-REGIONS: Europe, Japan and CanadaChristelle Anquez Office of International Programs US Food and Drug Administration -Public meet... ... more>>
FDADocs 5/5/2008 | 0 (0) | 5 | 0 | 0 | English
The Inspection is Over ??? What Happens Next? Possible FDA Enforcement ActionsPatricia HolobaughFDA Center for Biologics Evaluation and Research Division of Inspections and SurveillanceThe ... more>>
|